DIFFERENTIAL MAGE-1 GENE-EXPRESSION IN 2 VARIANTS OF AN ERYTHROLEUKEMIC CELL-LINE (K562)

被引:5
|
作者
SERRANO, A [1 ]
GARCIA, A [1 ]
ABRIL, E [1 ]
GARRIDO, F [1 ]
RUIZCABELLO, F [1 ]
机构
[1] UNIV GRANADA,HOSP VIRGAN NIEVES,IMMUNOL LAB,E-18014 GRANADA,SPAIN
关键词
D O I
10.1016/S0171-2985(11)80111-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The MAGE-1 gene encodes an antigen recognized on melanoma cells by autologous cytotoxic T cells. This gene shows a wide range of expression in many human turners bur not in normal tissues except for testes. We used reverse transcription polymerase chain reaction assays to analyze the expression of the MAGE-1 gene in two variants of an erythroleukemic cell line, K562. Comparison of two variants of the K562 cell line in different stages of differentiation showed different patterns of expression of the MAGE-1 gene. The more undifferentiated cell line (K562A) expressed high levels of specific MAGE-1 mRNA, in contrast to K562B, which features of erythroid differentiation, without MAGE-1 expression. Interestingly, we could not modulate MAGE-1 gene expression when in vitro differentiation of K562A was induced with Ara-C. Finally, our data indicate that MAGE-1 expression is not necessary for the maintenance of the transformed phenotype.
引用
收藏
页码:449 / 456
页数:8
相关论文
共 50 条
  • [21] POSITIVE AND NEGATIVE REGULATION OF SPECIFIC GENE-EXPRESSION BY THE TUMOR PROMOTER TPA IN HUMAN ERYTHROLEUKEMIC K562 CELLS
    SIEBERT, PD
    FUKUDA, M
    FEDERATION PROCEEDINGS, 1985, 44 (05) : 1652 - 1652
  • [22] Gene Expression Profile Regulated by CREB in K562 Cell Line
    Xia, H.
    Gong, Z.
    Lian, Y.
    Zhou, J.
    Wang, X.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2221 - 2234
  • [23] Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line
    Rafferty, SP
    Domachowske, JB
    Malech, HL
    BLOOD, 1996, 88 (03) : 1070 - 1078
  • [24] MECHANISM OF DIFFERENTIATION OF HUMAN ERYTHROLEUKEMIC CELL-LINE K-562 BY HEMIN
    BALIGA, BS
    MANKAD, M
    SHAH, AK
    MANKAD, VN
    CELL PROLIFERATION, 1993, 26 (06) : 519 - 529
  • [25] CHARACTERIZATION OF A K562 MULTIDRUG-RESISTANT CELL-LINE
    YANOVICH, S
    HALL, RE
    GEWIRTZ, DA
    CANCER RESEARCH, 1989, 49 (16) : 4499 - 4503
  • [26] ABSENCE OF ERYTHROCYTIC COMPONENTS IN THE ORIGINAL K562 CELL-LINE
    LOZZIO, BB
    LOZZIO, CB
    INTERNATIONAL JOURNAL OF CANCER, 1979, 24 (04) : 513 - 513
  • [27] EFFECTS OF FAGARONINE ON THE HUMAN CELL-LINE K562 CYCLE
    COMOE, L
    CARPENTIER, Y
    DESOIZE, B
    JARDILLIER, JC
    BULLETIN DU CANCER, 1988, 75 (07) : 691 - 691
  • [28] SUPPRESSOR SUBSTANCE PRODUCED BY THE K562 CELL-LINE INVITRO
    KORZELIUS, JM
    BEALMEAR, PM
    HOLTERMANN, OA
    JOURNAL OF SURGICAL ONCOLOGY, 1983, 23 (01) : 16 - 20
  • [29] MEGAKARYOBLASTIC DIFFERENTIATION OF PROERYTHROBLASTIC K562 CELL-LINE CELLS
    TETTEROO, PAT
    MASSARO, F
    MULDER, A
    SCHREUDERVANGELDER, R
    BORNE, AEGKV
    LEUKEMIA RESEARCH, 1984, 8 (02) : 197 - 206
  • [30] INDUCTION OF CYTOSKELETAL VIMENTIN AND ACTIN GENE-EXPRESSION BY A TUMOR-PROMOTING PHORBOL ESTER IN THE HUMAN-LEUKEMIC CELL-LINE K562
    SIEBERT, PD
    FUKUDA, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1985, 260 (06) : 3868 - 3874